On the origin of matrix metalloproteinase-2 and -9 in blood platelets

References

• Goetzl EJ, Banda MJ, Leppert D. Matrix metalloproteinases in immunity. J Immunol 1996; 156: 1–4
   PubMed Web of Science ®Google Scholar
• Lane WJ, Dias S, Hattori K, Heissig B, Choy M, Rabbany SY, Wood J, Moore MAS, Rafii S. Stromal-derived factor 1-induced megakaryocyte migration and platelet production is dependent on matrix metalloproteinases. Blood 2000; 96: 4152–4159
   PubMed Web of Science ®Google Scholar
• Sawicki G, Salas E, Murat J, Miszta-Lane H, Radomski MW. Release of gelatinase A during platelet activation mediates aggregation. Nature 1997; 386: 616–619
   PubMed Web of Science ®Google Scholar
• Santos-Martinez MJ, Medina C, Jurasz P, Radomski MW. Role of metalloproteinases in platelet function. Thromb Res 2007; 121: 535–542
   PubMed Web of Science ®Google Scholar
• Falcinelli E, Guglielmini G, Torti M, Gresele P. Intraplatelet signaling mechanisms of the priming effect of matrix metalloproteinase-2 on platelet aggregation. J Thromb Haemost 2005; 3: 2526–2535
   PubMed Web of Science ®Google Scholar
• Fernandez-Patron C, Martinez-Cuesta SE, Sawicki G, Wozniak M, Radomski MW, Davidge ST. Differential regulation of platelet aggregation by matrix metalloproteinase-9 and 2. Thromb Haemost 1999; 82: 1730–1735
   PubMed Web of Science ®Google Scholar
• Choi W-S, Jeon O-H, Kim H-H, Kim D-S. MMP-2 regulates human platelet activation by interacting with integrin αIIbβ3. J Thromb Haemost 2008; 6: 517–23
   PubMed Web of Science ®Google Scholar
• Sheu JR, Fong TH, Liu CM, Shen MY, Chen TL, Chang Y, Lu MS, Hsiao G. Expression of matrix metalloproteinase-9 in human platelets: Regulation of platelet activation in in vitro and in vivo studies. Br J Pharmacol 2004; 143: 193–201
   PubMed Web of Science ®Google Scholar
• Lee YM, Lee JJ, Shen MY, Hsiao G, Sheu JR. Inhibitory mechanisms of activated matrix metalloproteinase-9 on platelet activation. Br J Pharmacol 2006; 537: 52–58
   Google Scholar
• Jurasz P, Chung AWY, Radomski A, Radomski MW. Nonremodeling properties of matrix metalloproteinases: The platelet connection. Circ Res 2002; 90: 1041–1043
   PubMed Web of Science ®Google Scholar
• Galis ZS, Khatri JJ. Matrix metalloproteinases in vascular remodeling and atherogenesis: The good, the bad, and the ugly. Circ Res 2002; 90: 251–262
   PubMed Web of Science ®Google Scholar
• Jurasz P, Sawicki G, Duszyk M, Sawicka J, Miranda C, Mayers I, Radomski MW. Matrix metalloproteinase-2 in tumor-cell induced platelet aggregation: Regulation by NO. Cancer Res 2001; 61: 376–382
   PubMed Web of Science ®Google Scholar
• Galt SW, Lindemann S, Allen L, Medd DJ, Falk JM, McIntyre TM, Prescott SM, Kraiss LW, Zimmerman GA, Weyrich AS. Outside-in signals delivered by matrix metalloproteinase-1 regulate platelet function. Circ Res 2002; 90: 1093–1099
   PubMed Web of Science ®Google Scholar
• Colciaghi FB, Pastorino L, Marcello E, Zimmermann M, Cattabeni F, Padovani A, Di Luca M. [Alpha]-Secretase ADAM10 as well as [alpha]APPs is reduced in platelets and CSF of Alzheimer disease patients. Mol Med 2002; 8: 67–74
   PubMed Web of Science ®Google Scholar
• Bergmeier W, Piffath CL, Cheng G, Dole VS, Zhang Y, von Andrian UH, Wagner DD. Tumor necrosis factor-{alpha}-converting enzyme (ADAM17) mediates gpib{alpha}shedding from platelets in vitro and in vivo. Circ Res 2004; 95: 677–683
   PubMed Web of Science ®Google Scholar
• Rabie T, Strehl A, Ludwig A, Nieswandt B. Evidence for a role of ADAM17 (TACE) in the regulation of platelet glycoprotein V. J Biol Chem 2005; 280: 14462–14468
   PubMed Web of Science ®Google Scholar
• Galt SW, Lindemann S, Medd D, Allen LL, Kraiss LW, Harris ES, Prescot SM, McIntyre TM, Weyrich AS, Zimmerman GA. Differential regulation of Matrix Metalloproteinase-9 by monocytes adherent to collagen and platelets. Circ Res 2001; 89: 509–516
   PubMed Web of Science ®Google Scholar
• Lindenmeyer F, Legrand Y, Menashi S. Upregulation of MMP-9 expression in MDA-MB231 tumor cells by platelet granular membrane. FEBS Lett 1997; 418: 19–22
   PubMed Web of Science ®Google Scholar
• Kälvegren H, Jönsson S, Jonasson L. Release of matrix metalloproteinases-1 and -2, but not -9, from activated platelets measured by enzyme-linked immunosorbent assay. Platelets 2011; 22: 572–578
   PubMed Web of Science ®Google Scholar
• Cecchetti L, Tolley ND, Michetti N, Bury L, Weyrich AS, Gresele P. Megakaryocytes differentially sort mRNAs for matrix metalloproteinases and their inhibitors into platelets: A mechanism for regulating synthetic events. Blood 2011; 118: 1903–1911
   PubMed Web of Science ®Google Scholar
• Mustard JF, Perry DW, Ardli NG, Packham MA. Preparation of suspension of washed platelets from humans. Br J Haematol 1972; 22: 193–204
   PubMed Web of Science ®Google Scholar
• Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156–159
   PubMed Web of Science ®Google Scholar
• Emara M, Wozniak M. In vitro inhibition of human MMP-2 collagenolytic and gelatinolytic activity by neutralizing monoclonal antibodies. Immunol Invest 2010; 39: 833–848
   PubMed Web of Science ®Google Scholar
• Leber TM, Balkwill FR. Zymography: A single-step staining method for quantitation of proteolytic activity on substrate gels. Anal Biochem 1997; 249: 24–28
   PubMed Web of Science ®Google Scholar
• Sawicki G, Sanders EJ, Salas E, Wozniak M, Rodrigo J, Radomski MW. Localization and translocation of MMP-2 during aggregation of human platelets. Thromb Haemost 1998; 80: 836–839
   PubMed Web of Science ®Google Scholar
• Ault KA, Rinder HM, Mitchell J, Carmody MB, Vary CPH, Hillman RS. The significance of platelets with increased RNA content (reticulated platelets): A measure of the rate of thrombopoiesis. Am J Clin Pathol 1992; 98: 637–646
   PubMed Web of Science ®Google Scholar
• Harrison P, Wilbourn B, Debili N, Vainchenker J, Breton-Gorius J, Lawrie AS, Masse JM, Savidge GF, Cramer EM. Uptake of plasma fibrinogen into the alpha granules of human megakaryocytes and platelets. J Clin Invest 1989; 84: 1320–1324
   PubMed Web of Science ®Google Scholar
• Werb Z. ECM and cell surface proteolysis: Regulating cellular ecology. Cell 1997; 91: 439–442
   PubMed Web of Science ®Google Scholar
• Tayebjee MH, Lip GYH, Blann AD, MacFadyen RJ. Effects of age, gender, ethnicity, diurnal variation and exercise on circulating levels of matrix metalloproteinases (MMP)-2 and -9, and their inhibitors, tissue inhibitors of matrix metalloproteinases (TIMP)-1 and -2. Thromb Res 2005; 115: 205–210
   PubMed Web of Science ®Google Scholar
• Ray JM, Stetler-Stevenson WG. The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis and angiogenesis. Eur Respir J 1994; 7: 2062–2072
   PubMed Web of Science ®Google Scholar
• Falcinelli E, Bury L, Tolley N, Malvestiti M, Cecchetti L, Weyrich A, Gresele P. Response: MMP-9 in platelets: Maybe, maybe not. Blood 2011; 118: 6471–6473
   Web of Science ®Google Scholar
• Mannello F, Medda V. Differential expression of MMP-2 and MMP-9 activity in megakaryocytes and platelets. Blood 2011; 118: 6470–6471
   PubMed Web of Science ®Google Scholar